HomeHOFBF • OTCMKTS
add
Hofseth Biocare ASA
In the news
Financials
Income Statement
Revenue
Net income
| (NOK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 54.89M | -19.15% |
Operating expense | 50.11M | 1.40% |
Net income | -28.31M | 19.14% |
Net profit margin | -51.58 | -0.02% |
Earnings per share | — | — |
EBITDA | -27.12M | -29.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (NOK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.48M | 180.09% |
Total assets | 391.35M | 7.13% |
Total liabilities | 419.19M | 59.85% |
Total equity | -27.85M | — |
Shares outstanding | 411.08M | — |
Price to book | -2.38 | — |
Return on assets | -19.65% | — |
Return on capital | -28.85% | — |
Cash Flow
Net change in cash
| (NOK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -28.31M | 19.14% |
Cash from operations | 1.27M | 109.82% |
Cash from investing | -4.54M | -1,193.73% |
Cash from financing | 710.00K | -93.77% |
Net change in cash | -2.56M | -32.92% |
Free cash flow | 7.24M | 193.72% |
About
Founded
2000
Website
Employees
75
